Echo IQ is trading 5% down at A$0.57, with no confirmed company-specific catalyst identified for October 2, 2026.

  • The ASX announcement list shows no October 1 update; the latest listed company announcement is the September 17 EchoSolv HF FDA application update.
  • Broader market indicators supplied for October 1 were near flat and do not clearly explain the stock-specific move.